GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (BSP:BIIB34) » Definitions » Days Payable

Biogen (BSP:BIIB34) Days Payable : 65.96 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Biogen Days Payable?

Biogen's average Accounts Payable for the three months ended in Mar. 2024 was R$1,952 Mil. Biogen's Cost of Goods Sold for the three months ended in Mar. 2024 was R$2,700 Mil. Hence, Biogen's Days Payable for the three months ended in Mar. 2024 was 65.96.

The historical rank and industry rank for Biogen's Days Payable or its related term are showing as below:

BSP:BIIB34' s Days Payable Range Over the Past 10 Years
Min: 64.46   Med: 76.29   Max: 99.65
Current: 65.56

During the past 13 years, Biogen's highest Days Payable was 99.65. The lowest was 64.46. And the median was 76.29.

BSP:BIIB34's Days Payable is ranked worse than
62.22% of 974 companies
in the Drug Manufacturers industry
Industry Median: 89.21 vs BSP:BIIB34: 65.56

Biogen's Days Payable declined from Mar. 2023 (67.88) to Mar. 2024 (65.96). It may suggest that Biogen accelerated paying its suppliers.


Biogen Days Payable Historical Data

The historical data trend for Biogen's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Days Payable Chart

Biogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.26 88.80 86.77 90.25 66.96

Biogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.88 74.86 60.72 62.49 65.96

Competitive Comparison of Biogen's Days Payable

For the Drug Manufacturers - General subindustry, Biogen's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogen's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogen's Days Payable distribution charts can be found below:

* The bar in red indicates where Biogen's Days Payable falls into.



Biogen Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biogen's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2578.114 + 1976.089) / 2 ) / 12413.153*365
=2277.1015 / 12413.153*365
=66.96

Biogen's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (1976.089 + 1927.183) / 2 ) / 2700.048*365 / 4
=1951.636 / 2700.048*365 / 4
=65.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogen Days Payable Related Terms

Thank you for viewing the detailed overview of Biogen's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogen (BSP:BIIB34) Business Description

Address
225 Binney Street, Cambridge, MA, USA, 02142
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.

Biogen (BSP:BIIB34) Headlines

No Headlines